MONTREAL, June 8, 2020 /CNW Telbec/ - Arylide Life Sciences Inc. and Axcelon Biopolymers Corp. in collaboration with the Office of Applied Research and Innovation (OARI) located in Collège La Cité, in Ottawa have successfully secured a research grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) to develop an advanced protective bio-mask based on a patented bacterial nanocellulose technology.
The objective of the project under the special NSERC COVID-19 related program is to deploy a unique bacterial nanocellulose material embedded in an activated carbon matrix, coated with antimicrobial nanoparticles to develop a reusable advanced protective facial mask for healthcare professionals.
Dr. Chandra Panchal, CEO of Axcelon commented "Axcelon is a leader in the development of bacterial nanocellulose-based medical devices, including unique wound dressings currently commercialized. The development of an advanced, 3D-printed, effective, antimicrobial and comfortable face mask for use particularly by medical personnel, was deemed to be an essential extension of our capabilities."
Mike Fiorentino, CEO of Arylide commented, "We are pleased to be involved in the development of this Canadian innovation as it marks yet another major milestone for our company. We're proud of the partnerships that we are fostering with biomedical companies, academia and government to leverage innovative technologies and to bring state-of-the-art products to market."
The project will be conducted by a multi-disciplinary team of researchers, part of the OARI led by Dr. Nathalie Méthot of Collège La Cité who bring expertise in microbiology (level II biosafety laboratories) in the Technology Access Center in Bio-Innovation (TAC-B) along with the 3D printing in the Center of Expertise in Smart Prototyping (CEPI).
About Axcelon Biopolymers Corp.
Axcelon Biopolymers Corp., based in London, Ontario is an innovative biomaterials company focused on leveraging its unique BNC platform technology to develop bacterial cellulose-based, high value products for wound care, medical devices, and industrial applications. Axcelon holds over 14 patents related to BNC and BNC composites for biomedical applications.
About Arylide Life Sciences Inc.
Arylide Life Sciences Inc. is a Montreal, Quebec based company focused on developing and commercializing innovative products in dermatology, aesthetic medicine, plastic surgery and regenerative medicine.
About TAC-B and CEPI of La Cité.
TAC-B develops applied research partnerships through diverse federal and provincial financing. The CEPI lab is equipped with 3D printers and an artificial intelligence infrastructure that allows entrepreneurs to collaborate with researchers in a range of smart manufacturing fields.
Offering more than 140 programs in state-of-the-art facilities in a learning environment based on modern and forward-looking experiential practices, La Cité is the largest French-language college of applied arts and technology in Ontario and outside Quebec.
SOURCE Arylide Life Sciences Inc.